Cefazolin versus cloxacillin in methicillin-susceptible Staphylococcus aureus endocarditis: Too good to be true? Authors' reply

被引：0
|
作者：
Herrera-Hidalgo, Laura [1 ,2 ,3 ]
de Alarcon, Aristides [2 ,3 ]
机构：
[1] Univ Hosp Virgen del Rocio, Dept Pharm, Seville, Spain
[2] Univ Seville, Univ Hosp Virgen del Rocio, Spanish Natl Res Council, Inst Biomed Seville,Dept Infect Dis Microbiol & Pa, Seville, Spain
[3] Inst Salud Carlos III, CIBER Enfermedades Infecciosas CIBERINFEC, Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2024年 / 142卷
关键词：
D O I：
10.1016/j.ijid.2024.02.022
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children
    McNeil, J. Chase
    Sommer, Lauren M.
    Boyle, Mary
    Hogan, Patrick
    Vallejo, Jesus G.
    Hulten, Kristina G.
    Flores, Anthony R.
    Kaplan, Sheldon L.
    Fritz, Stephanie
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [22] A Test for the Rapid Detection of the cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus
    Rincon, Sandra
    Carvajal, Lina P.
    Gomez-Villegas, Sara, I
    Echeverri, Aura M.
    Rios, Rafael
    An Dinh
    Pedroza, Claudia
    Ordonez, Karen M.
    Nannini, Esteban
    Sun, Zhizeng
    Fowler, Vance G.
    Murray, Barbara E.
    Miller, William R.
    Palzkill, Timothy
    Diaz, Lorena
    Arias, Cesar A.
    Reyes, Jinnethe
    JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (04)
  • [23] The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections
    Flynt, Lauren K.
    Kenney, Rachel M.
    Zervos, Marcus J.
    Davis, Susan L.
    INFECTIOUS DISEASES AND THERAPY, 2017, 6 (02) : 225 - 231
  • [24] β-Lactam Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus Infective Endocarditis
    Jean, Baptiste
    Crolle, Maelys
    Pollani, Candice
    Le Guilloux, Adele
    Martin-Blondel, Guillaume
    Tattevin, Pierre
    Le Bot, Audrey
    Paz, David Luque
    Guerin, Francois
    Cattoir, Vincent
    Armand-Lefevre, Laurence
    Gueye, Signara
    Lescure, Francois-Xavier
    Duval, Xavier
    Massip, Clemence
    Delobel, Pierre
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [25] In Vivo Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against Cefazolin
    Nannini, Esteban C.
    Singh, Kavindra V.
    Arias, Cesar A.
    Murray, Barbara E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (09) : 4276 - 4281
  • [26] Methicillin-susceptible Staphylococcus aureus:: Believe it, or not
    Sakoulas, G
    Degirolami, PC
    Gold, HS
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (09) : 1237 - 1238
  • [27] β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins
    Li, Julius
    Echevarria, Kelly L.
    Traugott, Kristi A.
    PHARMACOTHERAPY, 2017, 37 (03): : 346 - 360
  • [28] The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections
    Lauren K. Flynt
    Rachel M. Kenney
    Marcus J. Zervos
    Susan L. Davis
    Infectious Diseases and Therapy, 2017, 6 : 225 - 231
  • [29] InfliximabPsoriasis and methicillin-susceptible Staphylococcus aureus
    Reactions Weekly, 2024, 2009 (1) : 310 - 310
  • [30] Cefazolin: A well-tolerated treatment for methicillin-susceptible Staphylococcus aureus complicated bacteremia
    Valour, F.
    MEDECINE ET MALADIES INFECTIEUSES, 2015, 45 (04): : 144 - 145
12345